Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

ACAT inhibitors from Sankyo

June 14, 1996

Hyperlipidemia treatment from Takeda

June 14, 1996

Ligand/Wyeth-Ayerst collaboration extended

June 14, 1996

Phase I trial to begin for aerosolized form of osteoporosis drug

June 14, 1996

Sanofi Winthrop launches tiludronic acid

June 14, 1996

La Jolla Cancer Research Foundation claims mammalian trophinin

June 7, 1996

Zomacton, human growth hormone now available in Italy

June 7, 1996

Torii and Asahi Brewery report aldose reductase inhibitors

June 7, 1996

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

Sanguine's PHER-02 development

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...